| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.8 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.8 |